Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 2—February 2003
Research

Molecular Typing of IberoAmerican Cryptococcus neoformans Isolates

Wieland Meyer*Comments to Author , Alexandra Castañeda†, Stuart Jackson*‡, Matthew Huynh*, Elizabeth Castañeda†, and the IberoAmerican Cryptococcal Study Group
Author affiliations: *University of Sydney, Sydney, Australia; †Instituto Nacional de Salud, Bogotá, Colombia; ‡University of Western Sydney, Campbelltown, Australia

Main Article

Figure 1

Geographic distribution of the molecular types obtained from IberoAmerican Crptococcus neoformans isolates by polymerase chain reaction fingerprinting and URA5 gene restriction fragment length polymorphis analysis (total numbers studied per country given in parentheses).

Figure 1. Geographic distribution of the molecular types obtained from IberoAmerican Crptococcus neoformans isolates by polymerase chain reaction fingerprinting and URA5 gene restriction fragment length polymorphis analysis (total numbers studied per country given in parentheses).

Main Article

1Members of the IberoAmerican Cryptococcal Study Group: Argentina: Alicia Arechavala, Hospital de Infecciosas Francisco J. Muñiz, Buenos Aires; Graciela Davel, Laura Rodero, Diego Perrotta, Departamento Micología, Instituto Nacional de Enfermedades Infecciosas “Dr. Carlos Gregorio Malbrán,” Buenos Aires; Brazil: Marcia Lazera, Ricardo Pereira-Igreja, Bodo Wanke, Laboratorio de Micologia Medica, Hospital Evandro Chagas, Fundaςao Oswaldo Cruz, Rio de Janeiro; Maria Jose Mendes-Giannini, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista (UNESP), Araraquara; Marcia S.C. Melhem, Adolfo Lutz Institute Seςao de Micologia, São Paulo; Marlene Henning-Vainstein, Centro de Biotecnologia (UFRGS), Porto Alegre; Chile: Maria Cristina Díaz, Programa de Microbiología y Micología, Universidad de Chile, Santiago; Colombia: Angela Restrepo, Corporación para Investigaciones Biológicas, Medellín; Sandra Huérfano, Instituto Nacional de Salud, Bogotá; Guatemala: Blanca Samayoa, Hospital San Juan de Dios, Guatemala City; Heidi Logeman, Universidad de San Carlos, Guatemala City; Mexico: Rubén López Martínez, Laura Rocío Castañon Olivares, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, México City; Cudberto Contreras-Peres, José Francisco Valenzuela Tovar, Instituto Nacional de Diagnóstico y Referencia Epidemiológicos , Mexico City; Peru: Beatriz Bustamante, Instituto de Medicina Tropical Alexander Humboldt, Lima; Spain: Joseph Torres-Rodriquez, Yolanda Morera, Grup de recerca en Micologia Experimental i Clínica, Institut Municipal d’Investigació Médica, Univesitat Autonoma de Barcelona, Barcelona; Venezuela: Belinda Calvo, Universidad del Zulia, Maracaibo

Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external